/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Digital follow-up program for patients undergoing atrial fibrillation ablation: a pilot single-center study
Event: ESC Congress 2023
Topic: Telehealth
Session: Advancements in cardiovascular telecare
Echocardiographic assessment of the right heart in patients with aortic stenosis undergoing transcatheter aortic valve implantation: analysis from a large single-center cohort
Event: ESC Congress 2023
Topic: Valvular Heart Disease
Session: Valvular heart disease: echocardiography and beyond
Sex differences in aortic stenosis progression and myocardial response
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Improving risk stratification in aortic stenosis: from the valve to the ventricle
Recognizing HCM and HF: making the diagnosis
Event: Heart Failure 2023
Topic: Myocardial Disease
Session: Hypertrophic cardiomyopathy and heart failure: exploring new options
A middle-age diagnosis of apical hypertrophic cardiomyopathy: there is more than meets the eye
Event: EACVI 2023
Topic: Cross-Modality and Multi-Modality Imaging Topics
Session: Myocardial and Pericardial Disease 2
A double menace in the heart: concomitant left atrial and left ventricular masses
Event: EACVI 2023
Topic: Echocardiography
Session: Arrhythmias 1
Right heart echocardiographic parameters and outcomes of patients with aortic stenosis after transcatheter aortic valve implantation
Event: EACVI 2023
Topic: Valvular Heart Disease
Session: Aortic Stenosis 1
Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort
Event: ESC Congress 2022
Topic: Hypertrophic Cardiomyopathy
Session: Hypertrophic cardiomyopathy: not so rare, but not so easy
Response and long-term outcomes with resynchronization therapy: the role of heart failure etiology
Event: ESC Congress 2022
Topic: Cardiac Resynchronisation Therapy (CRT)
Session: Chronic heart failure - ICD, device and cardiac resynchronisation therapy
Predictors of left ventricular dysfunction in hypertrophic cardiomyopathy: results from a nationwide registry
Event: ESC Congress 2022
Topic: Hypertrophic Cardiomyopathy
Session: Insights in hypertrophic cardiomyopathy and Chagas‘ disease
ESC 365 is supported by
